Event Calendar

Tuesday, July 16, 2024

Heart Failure in Cardiac Amyloidosis

Start Date: 7/16/2024 6:00 PM EDT
End Date: 7/16/2024 8:30 PM EDT

Organization Name: ASNC

ASNC Staff
Email: info@asnc.org
Phone: (703) 459-2555

Heart Failure in Cardiac Amyloidosis:
Suspecting and Diagnosing Transthyretin Amyloid Cardiomyopathy in Underdiagnosed Populations at Risk for Heart Failure

Join us July 16, 2024, to learn the signs and symptoms of heart failure in patients at risk for Cardiac Amyloidosis as well as latest diagnosis and treatment options.

Led by Program Chair, J. Clay Hays, Jr., MD, this program will focus on how to:

Recognize barriers to identification and diagnosis of (ATTR-CM) in patients at risk for Heart Failure.
Identify “Red Flags” and other markers of disease that raise suspicion and need for further testing.
Summarize the diagnostic evaluation for ATTR-CM including the differential diagnosis.
Demonstrate the importance of multimodality imaging in diagnosing ATTR-CM.
Discuss the importance of genetic testing and counseling.
Provide details of bone scintigraphy protocols and the importance of SPECT and SPECT/CT imaging, interpretation, and components of an appropriate report.
Evaluate existing and new treatments for patients with ATTR-CM.

Registration is complimentary for ASNC members!

Who Should Attend?

You should attend this program if you are part of the multidisciplinary care team involved with cardiac amyloidosis patients; primary care, general cardiologists, heart failure specialists, nuclear cardiologists, multimodality imaging cardiologists, technologists, hematologists, neurologists, nurse practitioners, nurses, and physician assistants.


Tuesday, July 16
6:00 PM - 8:30 PM EDT / 5:00 PM - 7:30 PM CDT

The program will consist of one, 2.5 hour virtual session. Only registered participants will have access to view the session recording.


2.5* CME/CE credits will be offered.
*Credits subject to change.

ASNC Members: Free
Non-Members: $25

Program Chair

J. Clay Hays, Jr., MD, Cardiologist
Jackson Heart and Vascular Center
Jackson, MS

This program is supported by an unrestricted educational grant from Pfizer.